Pectin and liver disease in animal studies
What it found
In rodents, pectin improved liver damage from fatty liver disease and alcohol, mainly by changing gut bacteria.
No human trials in liver disease have been published.
What they found
Studies in people
Human glucose effects
In healthy people, 10 or 15 g of pectin per day before a glucose challenge reduced glucose absorption and lowered post-meal blood sugar. An apple-rich diet also improved glucose handling.
Animal and lab studies
Gut bacteria changes
In rats and mice, pectin increased Bacteroides and decreased Firmicutes. In high-fat diet studies, the Bacteroides to Firmicutes ratio consistently increased.
Fatty liver in rodents
In mice and rats fed a high-fat or cholesterol-rich diet, pectin reduced liver steatosis and lowered liver triglycerides and cholesterol. It also improved some markers of liver metabolism.
Alcohol liver disease
In mice given alcohol, pectin reduced steatosis and liver inflammation and improved leaky gut. It also changed bile acids and increased indole derivatives from gut bacteria.
Possible cancer risk
In one mouse study, pectin was linked to a weaker development of liver tumors compared to inulin, but the authors say this possible side effect needs more research.
Studies in people and animals
Cholesterol and glucose
Pectin lowered blood and liver cholesterol in hamsters, rats and mice. In humans, an apple-rich diet lowered cholesterol, but purified pectin studies were scarce and not conclusive for blood fats.
What the authors conclude
“As described above, the use of pectin in both NAFLD and MAF has shown promising results in animal models of these conditions, but no clinical trials in humans have yet been published.”
Also in their conclusions
- They say pectin has shown promising results in animal models of fatty liver disease and alcoholic liver disease, but has been mainly documented in rodents.
- They advise that clinical trials are needed to confirm the effects of pectin on both NAFLD/NASH and ALD in humans.
- They suggest that personalized nutrition and combinations with probiotics or bacterial products could help reduce the dose of pectin and improve tolerance.
How it was done
The authors wanted to review how pectin, a soluble fiber, might reduce liver injury in non-alcoholic fatty liver disease and alcoholic liver disease by changing gut bacteria.
They reviewed studies that gave pectin to rodents with diet-induced fatty liver disease or alcohol-induced liver disease, and looked at changes in liver damage, gut bacteria and bacterial products.
What it can’t tell you
- Most of the evidence comes from animal studies, so it cannot show what happens in people with liver disease.
- No clinical trials in humans with liver disease have been published, so the effects on human liver health are not known.
- The studies used different diets and types of pectin, making it hard to compare results or know the best dose for people.
Who paid
- Funding
- Funded by China Scholarship Council (from the PubMed record).
- Conflicts
- The authors declare no conflict of interest.
- Authors work at
- Université Paris-Saclay, France; Paris Center for Microbiome Medicine (PaCeMM) FHU, France
The paper
- Title
- Pectin in Metabolic Liver Disease
- Type
- ReviewThe authors read earlier studies and describe what they found. It isn’t a new study.
- Evidence
- Studies in people · animals · lab
- Summarised from
- Full text
- Cite
- Hu W, Cassard AM, Ciocan D (2022). Pectin in Metabolic Liver Disease. Nutrients. doi:10.3390/nu15010157Free full textPubMed 36615814DOI
Summary written 26 Sep 2026. Check it against the paper before it changes what you eat. How we summarise papers · Report an error